2026 NPPES data Pharmacist NPI 1881280535 PHARMD
Verify on CMS →

MATANA NAVABIAN, PHARMD

Pharmacist in PALM SPRINGS, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 340 beneficiaries · Pharmacist avg: 135
Generic prescribing
65%
generic claims · 35% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

MATANA NAVABIAN, PHARMD filed 1,229 Medicare Part D claims in 2023 as a Pharmacist in PALM SPRINGS, California, prescribing 65% generic.

1K
Part D claims, 2023
65%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MATANA NAVABIAN, PHARMD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,229 Top 22% higher than 78% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). This entry sits in this band. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about MATANA NAVABIAN, PHARMD?

Quality data not reported

NPI registry status

Active

Issued 12/16/2020

NPI 1881280535

Primary specialty

Pharmacist

High-volume

290,447 US NPIs in this specialty

Medicare Part D claims

1,229 810% vs specialty avg

2023 prescription claims

Specialty avg: 135

Specialty distribution in California

How Pharmacist compares to other specialties among California providers

California providers

Pharmacist share within California

1. Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MATANA NAVABIAN, PHARMD appears in the CMS NPPES registry as a Pharmacist provider holding PHARMD credentials at 1180 N INDIAN CANYON DR STE E140, PALM SPRINGS, CA, 92262, with a listed phone of (760) 323-1001. NPI 1881280535 was issued on 12/16/2020. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what NAVABIAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,229 prescription claims written by this provider, covering 340 Medicare beneficiaries and totaling roughly $385K in drug spend, split 35% brand-name and 65% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacist is a high-volume specialty nationwide, with 290,447 enrolled providers across 56 states and an average of 135 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1180 N INDIAN CANYON DR STE E140
PALM SPRINGS, CA 92262

Provider Details

NPI 1881280535
Specialty Pharmacist
Credentials PHARMD
Gender Female
NPI Issued 12/16/2020

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MATANA NAVABIAN, PHARMD. To verify MATANA NAVABIAN, PHARMD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

MATANA NAVABIAN, PHARMD — brand share 35.0%
Specialty average (est.)

35% brand-name claims vs 65% generic, on 1,229 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,229
Total Claims
$385K
Total Drug Cost
340
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,972
Total Day Supply
88,039
Brand vs Generic
35% brand / 65% generic
Brand Drug Cost
$358K
Generic Drug Cost
$21K

Patient Demographics

Average Patient Age
73.5 years
Avg HCC Risk Score
2.50
Gender Split
46% female / 54% male
Age Distribution
<65: 43, 65-74: 139, 75-84: 115, 85+: 43

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MATANA NAVABIAN, PHARMD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Warfarin Sodium
102
Ozempic
Semaglutide
65
Rosuvastatin Calcium
65
Jardiance
Empagliflozin
55
Atorvastatin Calcium
52
Spironolactone
52
Losartan Potassium
48
Entresto
Sacubitril/Valsartan
47
Lisinopril
36
Amlodipine Besylate
33

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacist Overview

How MATANA NAVABIAN, PHARMD fits within the Pharmacist landscape nationally.

290,447
Pharmacist Providers in US
56
States with Pharmacist
135
Avg Claims per Provider

MATANA NAVABIAN, PHARMD's 1,229 claims are above the specialty average of 135.

Nearby Pharmacist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as NAVABIAN.

Compare Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MATANA NAVABIAN, PHARMD's specialty?
MATANA NAVABIAN, PHARMD specializes in Pharmacist and practices in PALM SPRINGS, California. Credentials: PHARMD.
How much does MATANA NAVABIAN, PHARMD prescribe under Medicare Part D?
In 2023, MATANA NAVABIAN, PHARMD wrote 1,229 Medicare Part D claims totaling $385K in drug costs for 340 beneficiaries.
Where is MATANA NAVABIAN, PHARMD located?
MATANA NAVABIAN, PHARMD is located at 1180 N INDIAN CANYON DR STE E140, PALM SPRINGS, CA, 92262. Phone: (760) 323-1001.
What is MATANA NAVABIAN, PHARMD's NPI number?
MATANA NAVABIAN, PHARMD's National Provider Identifier (NPI) is 1881280535, issued on 12/16/2020.
Does MATANA NAVABIAN, PHARMD prescribe more brand-name or generic drugs?
MATANA NAVABIAN, PHARMD's prescribing is 35% brand-name and 65% generic drugs by claim count, with $358K in brand drug costs.
How many Pharmacist providers are there in the US?
There are 290,447 Pharmacist providers across 56 states in the US. The average Pharmacist provider writes 135 Medicare Part D claims per year.
What drugs does MATANA NAVABIAN, PHARMD prescribe most often?
Based on 2023 Medicare Part D data, MATANA NAVABIAN, PHARMD's most frequently prescribed drugs include Warfarin Sodium, Ozempic, Rosuvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MATANA NAVABIAN, PHARMD accept Medicare?
MATANA NAVABIAN, PHARMD appears in CMS Medicare data with 1,229 Part D claims and 340 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MATANA NAVABIAN, PHARMD's credentials?
MATANA NAVABIAN, PHARMD's NPI is 1881280535 with credentials PHARMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology